Fundraising Fox
/Companies
Sign in

cumulus-neuroscience

Belfast, GB · Founded 2015 · 35 employees on LinkedIn · 3 known investors

Find your way into cumulus-neuroscience

Sign up to see every warm intro you have to cumulus-neuroscience

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the cumulus-neuroscience team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Founders & leadership

cumulus-neuroscience was founded in 2015 by Brian Murphy.

BMBrian Murphy
Brian MurphyCo-Founder & CSOBrian Murphy holds education in engineering, cognitive science, computational neuroscience, and machine learning, with prior experience combining startup and research roles. As Co-Founder and Chief Scientific Officer of Cumulus Neuroscience, he applies data science methods to analyze brain activity data and cognitive states from neuroimaging technologies.
T
TinaCEO

Investors · 3

Clarendon Fund Managers Ltd.listed by Clarendon Fund Managers Ltd.Belfast · $63K – $3.8M

How we know: Clarendon Fund Managers Ltd.'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

LifeArc Ventureslisted by LifeArc VenturesLondon

Companies House · registry record

View on Companies House ↗
Registered name
CUMULUS NEUROSCIENCE LIMITED
Company number
NI628481
Status
Active
Company type
Private limited company
Incorporated
5 Jan 2015
Registered office
Unit 5, Concourse Building 3, Queens Road, Belfast, BT3 9DT
Nature of business (SIC)
62012 — Business and domestic software development
Previous names
BRAINWAVEBANK LTD. (2015–2020)
Accounts
last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement
last made up to 12 Sept 2025 · next due 26 Sept 2026

Current officers · 6

  • Robert Ballantine — director, appointed 13 Sept 2025
  • Brian Cummings — director, appointed 30 Apr 2025
  • Graham Ferguson — director, appointed 12 Jun 2025
  • Brian Murphy — director, appointed 12 Jun 2025
  • Ricardo Sainz Fuertes — director, appointed 1 Jan 2026
  • Tina Sampath — director, appointed 1 Sept 2024

Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does cumulus-neuroscience do?
NeuLogiq is a research platform for clinical trials that integrates tablet-based cognitive assessments, EEG monitoring, and real-world behavioral data to measure brain function changes. The platform serves biopharma sponsors and clinical research sites conducting central nervous system studies across phases 0-3.
Who founded cumulus-neuroscience?
cumulus-neuroscience was founded by Brian Murphy in 2015.
Who are cumulus-neuroscience's investors?
cumulus-neuroscience's investors include Dementia Discovery Fund, Clarendon Fund Managers Ltd., LifeArc Ventures.
Where is cumulus-neuroscience headquartered?
cumulus-neuroscience is headquartered in Belfast, GB.